Secretoneurin: A functional neuropeptide in health and disease

Peptides

Volumn 21, Issue 8, 2000, Pages 1289-1298

  Wiedermann, Christian J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Brain; Chromogranins; Human; Immune system; Leukocytes; Neuroimmunomodulation; Neuropeptides; Receptor; Secretogranin II

Indexed keywords

CHROMOGRANIN; NEUROPEPTIDE; SECRETOGRANIN II; SECRETONEURIN;

CENTRAL NERVOUS SYSTEM; DOPAMINE RELEASE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; NEUROENDOCRINE TUMOR; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; NEUROTRANSMISSION; NONHUMAN; ONTOGENY; PARACRINE SIGNALING; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMAL; CENTRAL NERVOUS SYSTEM; DOPAMINE; HUMAN; INFLAMMATION; KINETICS; MONOCYTES; NEOPLASMS; NEURONS; NEUROPEPTIDES; PROTEINS; RATS; XENOPUS;

EID: 0033785587     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00271-0     Document Type: Review

References (68)

1. Agneter E., Sitte H.H., Stockl-Hiesleitner S., Fischer-Colbrie R., Winkler H., Singer E.A. Sustained dopamine release induced by secretoneurin in the striatum of the rat a microdialysis study . J Neurochem. 65:1995;622-625.
2. Anouar Y., Jegou S., Alexandre D., Lihrmann I., Conlon J.M., Vaudry H. Molecular cloning of frog secretogranin-II reveals the occurrence of several highly conserved potential regulatory peptides. FEBS Lett. 394:1996;295-299.
3. Bergmann M., Kuchelmeister K., Schmid K.W., Kretzschmar H.A., Schroder R. Different variants of frontotemporal dementia a neuropathological and immunohistochemical study . Acta Neuropathol (Berlin). 92:1996;170-179.
4. Dun N.J., Dun S.L., Lin H.H., Hwang L.L., Saria A., Fischer-Colbrie R. Secretoneurin-like immunoreactivity in rat sympathetic, enteric and sensory ganglia. Brain Res. 760:1997;8-16.
5. Dunzendorfer S., Meierhofer C., Wiedermann C.J. Signaling in neuropeptide-induced migration of human eosinophils. J Leukoc Biol. 64:1998;828-834.
6. Dunzendorfer S., Schratzberger P., Reinisch N., Kahler C.M., Wiedermann C.J. Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils. Blood. 91:1998;1527-1532.
7. Eder U., Hukkanen M., Leitner B., et al. The presence of secretoneurin in human synovium and synovial fluid. Neurosci Lett. 224:1997;139-141.
8. Eder U., Fischer-Colbrie R., Kogner P., Leitner B., Bjellerup P., Winkler H. Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas. Neurosci Lett. 253:1998;17-20.
9. Eder U., Leitner B., Kirchmair R., et al. Levels and proteolytic processing of chromogranin A and B and secretogranin-II in cerebrospinal fluid in neurological diseases. J Neural Transm. 105:1998;39-51.
10. Egger C., Kirchmair R., Kapelari S., Fischer-Colbrie R., Hogue-Angeletti R., Winkler H. Bovine posterior pituitary presence of p65 (synaptotagmin), PC1, PC2 and secretoneurin in large dense core vesicles . Neuroendocrinology. 59:1994;169-175.
11. Fischer-Colbrie R., Laslop A., Kirchmair R. Secretogranin-II molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin . Prog Neurobiol. 46:1995;49-70.
12. Gruber B., Schratzberger P., Kahler C.M., et al. Staurosporine-dependent activation of human endothelial cell monolayers for neutrophil adherence by secretoneurin. Peptides. 18:1997;1445-1447.
13. Heym C., Klimaschewski L., Borghini N., Fischer-Colbrie R. Immunohistochemistry of small intensely fluorescent (SIF) cells and of SIF cell-associated nerve fibers in the rat superior cervical ganglion. Microsc Res Tech. 29:1994;143-150.
14. Hoflehner J., Eder U., Laslop A., Seidah N.G., Fischer-Colbrie R., Winkler H. Processing of secretogranin-II by prohormone convertases importance of PC1 in generation of secretoneurin . FEBS Lett. 360:1995;294-298.
15. Holthuis J.C., Martens G.J. The neuroendocrine proteins secretogranin-II and III are regionally conserved and coordinately expressed with pro-opiomelanocortin in Xenopus intermediate pituitary. J Neurochem. 66:1996;2248-2256.
16. Ischia R., Culig Z., Eder U., Bartsch G., Winkler H., Fischer-Colbrie R., Klocker H. Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell line. Prostate. 8:(suppl):1998;80-87.
17. Kähler C.M., Bellmann R., Reinisch N., Schratzberger P., Gruber B., Wiedermann C.J. Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin. Eur J Pharmacol. 304:1996;135-139.
18. Kähler C.M., Schratzberger P., Wiedermann C.J. Response of vascular smooth muscle cells to the neuropeptide secretoneurin. A functional role for migration and proliferation in vitro. Arterioscler Thromb Vasc Biol. 17:1997;2029-2035.
19. Kähler C.M., Kirchmair R., Kaufmann G., et al. Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro. Arterioscler Thromb Vasc Biol. 17:1997;932-939.
20. Kähler C.M., Kaufmann G., Hogue-Angeletti R., et al. A soluble gradient of the neuropeptide secretoneurin promotes the transendothelial migration of monocytes in vitro. Eur J Pharmacol. 365:1999;65-75.
21. Kaufmann W.A., Barnas U., Maier J., Saria A., Alheid G.F., Marksteiner J. Neurochemical compartments in the human forebrain evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala . Synapse. 26:1997;114-130.
22. Kaufmann W.A., Barnas U., Humpel C., et al. Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease. Eur J Neurosci. 10:1998;1084-1994.
23. Kirchmair R., Hogue-Angeletti R., Gutierrez J., Fischer-Colbrie R., Winkler H. Secretoneurin - a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin-II (chromogranin C). Neuroscience. 53:1993;359-365.
24. Kirchmair R., Marksteiner J., Troger J., et al. Human and rat primary C-fibre afferents store and release secretoneurin, a novel neuropeptide. Eur J Neurosci. 6:1994;861-868.
25. Kirchmair R., Benzer A., Troger J., et al. Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin-II (secretoneurin) in human and bovine cerebrospinal fluid. Neuroscience. 63:1994;1179-1187.
26. Klimaschewski L., Benndorf K., Kirchmair R., Fischer-Colbrie R., Heym C. Secretoneurin-immunoreactivity in nerve terminals apposing identified preganglionic sympathetic neurons in the rat colocalization with substance P and enkephalin . J Chem Neuroanat. 9:1995;55-63.
27. Klimaschewski L., Kroesen S., Eder U., Leitner B., Fischer-Colbrie R. Localization and axotomy-induced regulation of the peptide secretoneurin in the rat superior cervical ganglion. Eur J Neurosci. 8:1996;1953-1964.
28. Kong C., Gill B.M., Rahimpour R., et al. Secretoneurin and chemoattractant receptor interactions. J Neuroimmunol. 88:1998;91-98.
29. Laslop A., Weiss C., Savaria D., et al. Proteolytic processing of chromogranin B and secretogranin-II by prohormone convertases. J Neurochem. 70:1998;374-383.
30. Leitner B., Fischer-Colbrie R., Scherzer G., Winkler H. Secretogranin-II relative amounts and processing to secretoneurin in various rat tissues . J Neurochem. 66:1996;1312-1317.
31. Leitner B., Kaufmann W.A., Marksteiner J., et al. Ontogenic development of secretogranin-II and of its processing to secretoneurin in rat brain. Brain Res Dev Brain Res. 100:1997;161-168.
32. Leitner B., Schneitler C., Klocker H., et al. Formation and sequence analysis of secretoneurin, a neuropeptide derived from secretogranin-II, in mammalian, bird, reptile, amphibian and fish brains. Neurosci Lett. 248:1998;105-108.
33. Li J.Y., Leitner B., Winkler H., Dahlstrom A. Distribution of chromogranins A and B and secretogranin-II (secretoneurin) in rat pelvic neurons and vas deferens. Neuroscience. 84:1998;281-294.
34. Li J.Y., Leitner B., Lovisetti-Scamihorn P., Winkler H., Dahlstrom A. Proteolytic processing, axonal transport and differential distribution of chromogranins A and B, and secretogranin-II (secretoneurin) in rat sciatic nerve and spinal cord. Eur J Neurosci. 11:1999;528-544.
35. Liang F., Li J.Y., Lovisetti-Scamihorn P., et al. The processing of secretogranin-II in the peripheral nervous system release of secretoneurin from porcine sympathetic nerve terminals . Brain Res. 818:1999;459-467.
36. Mahata S.K., Mahata M., Hortnag H., et al. Concomitant changes of messenger ribonucleic acid levels of secretogranin-II, VGF, vasopressin and oxytocin in the paraventricular nucleus of rats after adrenalectomy and during lactation. J Neuroendocrinol. 5:1993;323-330.
37. Marksteiner J., Kirchmair R., Mahata S.K., et al. Distribution of secretoneurin, a peptide derived from secretogranin-II, in rat brain an immunocytochemical and radioimmunological study . Neuroscience. 54:1993;923-944.
38. Marksteiner J., Mahata S.K., Pycha R., Mahata M., Saria A., Fischer-Colbrie R., Winkler H. Distribution of secretoneurin immunoreactivity in the spinal cord and lower brainstem in comparison with that of substance P and calcitonin gene-related peptide. J Comp Neurol. 340:1994;243-254.
39. Marksteiner J., Saria A., Kirchmair R., et al. Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions. Eur J Neurosci. 5:1993;1573-1585.
40. Marksteiner J., Lassnig E., Telser S., et al. Evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala of the rat. J Comp Neurol. 353:1995;275-290.
41. McQueen D.S., Eder U., Timm M., et al. Secretoneurin. A novel carotid body peptide. Adv Exp Med Biol. 410:1996;329-333.
42. Miller C., Kirchmair R., Troger J., et al. CSF of neuroleptic-naive first-episode schizophrenic patients levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin-II (secretoneurin) . Biol Psychiatry. 39:1996;911-918.
43. Oulyadi H., Davoust D., Vaudry H. A determination of the solution conformation of secretoneurin, a neuropeptide originating from the processing of secretogranin-II, by 1H-NMR and restrained molecular dynamics. Eur J Biochem. 246:1997;665-673.
44. Overdick B., Kirchmair R., Marksteiner J., et al. Presence and distribution of a new neuropeptide, secretoneurin, in human retina. Peptides. 17:1996;1-4.
45. Pagani A., Fischer-Colbrie R., Eder U., Pellin A., Llombart-Bosch A., Bussolati G. Neural and mesenchymal differentiations in Ewing's sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidence. Int J Cancer. 63:1995;738-743.
46. Pagani A., Papotti M., Abbona G.C., Bussolati G. Chromogranin gene expressions in colorectal adenocarcinomas. Mod Pathol. 8:1995;626-632.
47. Plazquez M., Bosma P.T., Chang J.P., Docherty K., Trudeau V.L. Gamma-aminobutyric acid up-regulates the expressionn of a novel secretogranin-IImessenger ribonucleic acid in the goldfish pituitary. Endocrinology. 139:1998;4870-4880.
48. Pertl C., Kaufmann W., Amann R., et al. Secretoneurin, a novel neuropeptide, in the human dental pulp. Arch Oral Biol. 43:1998;361-365.
49. Prommegger R., Obrist P., Ensinger C., et al. Secretoneurin in carcinoids of the appendix-immunohistochemical comparison with chromogranins A, B and secretogranin-II. Anticancer Res. 18:1998;3999-4002.
50. Reinisch N., Kirchmair R., Kähler C.M., et al. Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett. 334:1993;41-44.
51. Saria A., Troger J., Kirchmair R., Fischer-Colbrie R., Hogue-Angeletti R., Winkler H. Secretoneurin releases dopamine from rat striatal slices a biological effect of a peptide derived from secretogranin-II (chromogranin C) . Neuroscience. 54:1993;1-4.
52. Saria A., Kaufmann W.A., Marksteiner J., Leitner B., Traurig H., Fischer-Colbrie R., Winkler H. Distribution and processing of secretoneurin in the developing rat brain. Ann NY Acad Sci. 814:1997;90-96.
53. Schmid K.W., Brink M., Freytag G., et al. Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells. Virchows Arch. 425:1994;127-132.
54. Schmid K.W., Kunk B., Kirchmair R., Tötsch M., Bocker W., Fischer-Colbrie R. Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin-II, in normal human endocrine and neuronal tissues. Histochem J. 27:1995;473-481.
55. Schmid K.W., Wolf C., Feldt B., Fischer-Colbrie R. Increased secretogranin-II protein and mRNA expression in C cells of the thyroid in Hashimoto's thyroiditis. Verh Dtsch Ges Pathol. 80:1996;247-249.
56. Schneitler C., Kähler C., Wiedermann C.J., Hogue-Angeletti R., Fischer-Colbrie R. Specific binding of a 125I-secretoneurin analogue to a human monocytic cell line. J Neuroimmunol. 86:1998;87-91.
57. Schratzberger P., Wöll E., Reinisch N., Kähler C.M., Wiedermann C.J. Secretoneurin-induced in vitro chemotaxis of human monocytes is inhibited by pertussis toxin and an inhibitor of protein kinase C. Neurosci Lett. 214:1996;208-210.
58. Schratzberger P., Reinisch N., Kähler C.M., Wiedermann C.J. Deactivation of chemotaxis of human neutrophils by priming with secretogranin-II-derived secretoneurin. Regul Pept. 63:1996;65-71.
59. Schratzberger P., Reinisch N., Prodinger W.M., et al. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol. 158:1997;3895-3901.
60. Schurmann G., Bishop A.E., Facer P., et al. Secretoneurin a new peptide in the human enteric nervous system . Histochem Cell Biol. 104:1995;11-19.
61. Schwarzer C., Marksteiner J., Kroesen S., Kohl C., Sperk G., Winkler H. Secretoneurin a market in rat hippocampal pathways . J Comp Neurol. 377:1997;29-40.
62. Simonneaux V., Vuillez P., Eder U., Miguez J.M., Pevet P., Fischer-Colbrie R. Secretoneurin a new neuropeptide in the rodent pineal gland . Cell Tissue Res. 288:1997;427-434.
63. Sprott H., Bradley L.A., Oh S.J., et al. Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue. Arthritis Rheum. 41:1998;1689-1694.
64. Storch M.K., Fischer-Colbrie R., Smith T., et al. Co-localization of secretoneurin immunoreactivity and macrophage infiltration in the lesions of experimental autoimmune encephalomyelitis. Neuroscience. 71:1996;885-893.
65. Telser S., Marksteiner J., Hinterhuber H., Saria A. Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human spinal cord. Neurosci Lett. 191:1995;83-86.
66. Tötsch M., Padberg B.C., Schroder S., et al. Secretoneurin in bronchopulmonary carcinoids - immunohistochemical comparison with chromogranins A and B and secretogranin-II. Histopathology. 26:1995;357-361.
67. Troger J., Kirchmair R., Marksteiner J., et al. Release of secretoneurin and noradrenaline from hypothalamic slices and its differential inhibition by calcium channel blockers. Naunyn-Schmiedebergs Arch Pharmacol. 349:1994;565-569.
68. You Z.B., Saria A., Fischer-Colbrie R., Terenius L., Goiny M., Herrera-Marschitz M. Effects of secretogranin-II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis. Naunyn-Schmiedebergs Arch Pharmacol. 354:1996;717-724.